retatrutide weight loss trial triple agonist Today we shared new results on retatrutide, an investigational, first Experimental drug Retatrutide shows promising

These findings highlight the importance of targeted therapeutic strategies based on HF phenotypes

Background As the use of weight-loss and diabetes medications continues to rise worldwide, more women of reproductive age are becoming pregnant while receiving these treatments, often before realizing they are expecting

The distinction between acute and chronic GLP-1 signaling matters enormously

As semaglutides popularity soars, rare but serious adverse effects are emerging

The Inflammation Control Stack: BPC-157 (gut healing and systemic inflammation reduction) Thymosin Alpha-1 (immune modulation) TB-500 (tissue repair and inflammation control) GHK-Cu (anti-inflammatory and regenerative effects) Chronic low-grade inflammation is at the root of metabolic dysfunction, fatigue, and brain fog